Notice of the 10th Annual General Meeting 2026
Dear Shareholders,
We would like to express our gratitude for your continued interest and unwavering support. It is thanks to your encouragement that we have been able to take significant steps forward in our challenging mission to develop innovative new medicines.
Our upcoming Annual General Meeting (AGM) is a meaningful opportunity for us to share our achievements over the past year and discuss our vision for a brighter future. We cordially invite you to attend, share your valuable insights, and witness the continued growth of Orum Therapeutics.
📅 Meeting Details (AGM & Webcast Access Info)
Date & Time: March 27, 2026, at 9:00 AM KST
Eligibility: Shareholder as of Dec 31st, 2025
Location: 3/F Conference Hall, Exhibition Center 1, DCC Daejeon Convention Center, 107 Expo-ro, Yuseong-gu, Daejeon, South Korea
Requirements: Valid photo ID
Webcast Application Period: March 23 9AM KST to March 26 4PM KST
Key Agenda:
Approval of the 10th Term Financial Statements
Appointment of Outside Directors
Online Participation
For shareholders who are unable to attend in person, we have arranged for real-time online participation. Please note that online voting will not be available for those joining via the webcast
Webcast: Register Here
Please contact IR for further assistance (ir@orumrx.com)
Important Notice:
· Attendance at the online General Meeting of Shareholders is not recognized as attendance at the General Meeting of Shareholders under the Commercial Act, nor are voting rights or the right to speak granted.
· This live broadcast is provided exclusively to the shareholder and viewing rights cannot be transferred to a third party.
· Screen capturing, recording, filming, reproduction, and external posting or distribution without the Company's consent are prohibited.
